Who is sponsoring NCT00994916?

NCT00994916 is sponsored by David Lacomis, MD.

What drugs are being tested in NCT00994916?

Interventions in NCT00994916: 3,4 diaminopyridine.

What condition does NCT00994916 study?

NCT00994916 studies Lambert-Eaton Myasthenic Syndrome.

Is NCT00994916 still recruiting?

NCT00994916 is currently no longer available. Last updated 9 July 2019.

Last reviewed 2019-07-09 · How we verify

NCT00994916

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

NO LONGER AVAILABLE Last updated 9 July 2019

What this trial tests

trial testing 3,4 diaminopyridine in Lambert-Eaton Myasthenic Syndrome. No longer available.

Quick facts

Lead sponsor	David Lacomis, MD
Status	NO LONGER AVAILABLE
Study type	EXPANDED_ACCESS

Drugs / interventions tested

3,4 diaminopyridine

Conditions studied

Lambert-Eaton Myasthenic Syndrome — all drugs for Lambert-Eaton Myasthenic Syndrome →

Sponsor

David Lacomis, MD

Who can join

18 and older, any sex, with Lambert-Eaton Myasthenic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to provide expanded access (compassionate use) of 3,4 diaminopyridine to patients with Lambert-Eaton myasthenic syndrome (LEMS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lambert-Eaton Myasthenic Syndrome

Currently open trials in the same condition.

NCT06441825 — Patient Observation With Environmental and Wearable Sensors in Myasthenia Gravis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00994916 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by David Lacomis, MD
Last refreshed: 9 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00994916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing